AI-generated summary
The authors report a double-blind randomized trial in which one socket of each patient with bilateral impacted mandibular third molars received photobiomodulation and the other received sham treatment after extraction. Photobiomodulation was associated with a lower frequency of alveolar osteitis than sham treatment (P = 0.035), and the authors suggest it may help reduce the risk of alveolar osteitis.
- Who or what was studied
- Patients with bilateral impacted mandibular third molars undergoing surgical extraction
- Wavelengths
- 660, 810 nm
- Limits stated in the abstract
- The abstract does not state the total number of participants, and the sample size is not reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 810 nm
- Power
- 200 mW, 312.5 mW, 400 mW
- Total energy
- 1J, 1.6 J, 3 J, 6 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Sham, Beam area. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.